LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a clinically and genetically heterogeneous lymphoid malignancy. The unsatisfactory outcome for refractory patients has prompted efforts to explore new therapeutic approaches for DLBCL. However, the mechanisms involved in treatment associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Guo, Xinhong, Zhan, Lingbo, Wang, Lei, Wang, Xinyou, Jiang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378962/
https://www.ncbi.nlm.nih.gov/pubmed/34422089
http://dx.doi.org/10.1155/2021/4468140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378962/
https://www.ncbi.nlm.nih.gov/pubmed/34422089
http://dx.doi.org/10.1155/2021/4468140

Ejemplares similares